Inhibition of both the mTOR and MEK/ERK pathways led to increased nuclear accumulation and activation of FoxO3a that promoted differentiation and reduced tumorigenicity of glioblastoma cancer stem-like cells [137]. Here, MAPK1 is linked to glioblastoma.